Category: Protocols

  • AUTO-SANGUIS THERAPY

    According to the teachings of Reckeweg’s homotoxicology, virtually every illness may be defined as either a defensive reaction by the organism against toxins or as the expression of toxic damage. It follows, therefore, that the blood of each patient contains those pathogenic poisons (homotoxins) typical of the disease from which that patient suffers.

    Through withdrawing a patient’s blood, then homeopathically potentising it over several levels and subsequently re-introducing it by means of hypodermic injection, Reckeweg holds that precisely these pathogenic poisons undergo modification to yield a homeopathically active therapeutic agent ideal for application in stimulation therapy. This agent stimulates the body’s defense systems thus increasing detoxification and promoting the healing process.

    According to Burgi’s Principle, the injection of appropriate homeopathic preparations intensifies efficacy of the potentised auto-sanguis blood to an even higher degree.

    Auto-sanguis therapy is a treatment designed to exert a counteractive effect against exogenic and endogenic homotoxins (including toxic deterioration of by-products from the body’s own cells), thus promoting the healing of chronic disease in harmony with the laws of nature.


    1. Withdraw 2–3 cc of the patient’s blood
    2. Expell contents of syringe
    3. Using the syringe and needle initially used for blood withdrawal, aspirate the appropriate Heel remedy (injeel, suis organ, etc.). It is best to use no more than 3 remedies. Once the remedy is in the syringe, cap the syringe and shake vigorously, about 10 times to potentise the mixture.

    This is the first potentisation which is then injected into the patient s.c. or i.m. (and i.a. & i.p. in an experimental nature).

    Intravenous injection is contraindicated in auto-sanguis therapy, as the degree of potentisation would be lost, and the intended action on the immune system would become questionable.

    Potentisation can be carried out up to 5 times. The number of stages you select should be adjusted according to your prognosis, professional judgment and familiarity with the patient.


    CONDITIONS THAT MAY BENEFIT FROM AUTO-SANGUIS THERAPY:

    • Iatrogenic conditions
    • Chronic viral and bacterial infections
    • Precancerous stages
    • Hepatic damage
    • Migraine
    • Chronic eczema
    • Bronchial asthma
    • Duodenal and gastric ulcers
    • Arthrosis
    • Lymphatic diathesis

    PROTOCOL FROM A CASE STUDY
    Case study by: Drs Ivo Bianchi & Jo Serrentino

    RE: 40 year old female Caucasian

    CONDITION: Lower back pain due to strain and possible cervical hernia. X-rays showed a small deviation (less than 5 degrees) of vertebra #5, without arthrosis or calcification. This deviation was congenital and no damage seemed evident. The condition worsened because of irritation of the sciatic nerve due to overexertion.

    PROCEDURE: 1–2 cc of patient’s blood was drawn into a sterile syringe. The blood was discarded, leaving only minute traces of the patient’s blood in the syringe. 2 cc of Discus compositum, 2 cc of Traumeel and 2 cc of Zeel were then aspirated into the emptied syringe (that still had traces of the patient’s blood). The injection was given s.c. in the region of the 5th vertebra.

    RESULTS: Although this patient’s condition was not serious or degenerative, but rather from injury, it was very painful and restricted movement. A treatment to relieve and, mostly halt the progress of the condition, was imperative. The auto-sanguis treatment was followed with intravenous injection of Traumeel and with the oral administration of Zeel, Traumeel and Discus comp. fragmented over two weeks.

    The patient claimed relief almost immediately, with a slight exacerbation within hours of the treatment lasting about 4 hours. The following day the patient was able to resume normal movement which progressively improved to full recovery without recurrence within the three year follow up period.

  • Cushing’s Protocol

    Take 8–10 drops of each preparation at the indicated times. These may be combined and repeated 2–4–6 times daily as needed.

    TimeHormeel S(Main remedy)Graphites-HomaccordGalium-HeelLymphomyosot
    8 a.m.
    9 a.m.
    10 a.m.
    11 a.m.
    12 noon
    1 p.m.
    2 p.m.
    3 p.m.
    4 p.m.
    5 p.m.
    6 p.m.
    7 p.m.

    Supporting Circulation Aid

    Ailment/GoalRemedyFormRouteFrequencyNotes
    Circulatory supportAesculus compositumAmpoulesoral¹DailyAlternate with core remedies

    Injection Therapy Options

    Ampoule Treatments

    RemedyFormRouteFrequencyNotes
    Hormeel SAmpoulei.m. / s.c. / i.v.2–6×/day²Rotate injection route
    Graphites-HomaccordAmpoulei.m. / s.c. / i.v.2–6×/day²
    Galium-HeelAmpoulei.m. / s.c. / i.v.2–6×/day²
    LymphomyosotAmpoulei.m. / s.c. / i.v.2–6×/day²

    Auto-sanguis Therapy

    ComponentFormRouteFrequencyNotes
    Hypophysis suis-InjeelAmpoulei.m. / s.c.As advisedPair with below
    Funiculus umbilicalis suis-InjeelAmpoulei.m. / s.c.As advisedAlternating use

    Glandular & Hormonal Support

    GoalRemedyFormRouteFrequencyNotes
    Thyroid supportThyreoidea compositumAmpoulei.m. / s.c.2–6×/day²
    Placental supportPlacenta compositumAmpoulei.m. / s.c.2–6×/day²
    Testicular support (M)Testis compositumAmpoulei.m. / s.c.2–6×/day²Men only
    Ovarian support (F)Ovarium compositumAmpoulei.m. / s.c.2–6×/day²Women only

    Nosodes & Complementary Injeels

    (Interpolate at intervals between other injections)

    RemedyFormRouteNotes
    Grippe-Nosode (forte)Ampoulei.m. / s.c.Acute infection support
    Diphtherinum (forte)Ampoulei.m. / s.c.
    Sinusitis-Nosode (forte)Ampoulei.m. / s.c.
    Staphylococcus-Injeel (forte)Ampoulei.m. / s.c.
    Glandula thyreoidea suis-Injeel (forte)Ampoulei.m. / s.c.
    Engystol N (optional)Ampoulei.m. / s.c.Additional immune support
    Traumeel S (optional)Ampoulei.m. / s.c.Anti-inflammatory

    Enzyme & Metabolic Support

    GoalRemedyFormRouteFrequencyNotes
    Coenzyme supportCoenzyme compositumAmpouleoral2–6×/day²
    Mitochondrial supportUbichinon compositum (optional)Ampouleoral2–6×/day²
    Citric Acid Cycle supportCatalysts of the Citric Acid Cycle Pack (optional)Ampouleoral2–6×/day²